N-(2-benzo[d]isoxazol-3-yl-acetyl)-methanesulfonamide | 1086463-08-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并异恶唑
• 英文名称: N-(2-benzo[d]isoxazol-3-yl-acetyl)-methanesulfonamide
• 英文别名: 2-(1,2-benzoxazol-3-yl)-N-methylsulfonylacetamide
• CAS: 1086463-08-2
• 化学式: C₁₀H₁₀N₂O₄S
• 分子量: 254.266
• InChiKey: ZKFXBILHNRHOHS-UHFFFAOYSA-N

物化性质

• 密度：
  1.445±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  97.6
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为产物：
  描述：

  甲基磺酰胺 、 1,2-苯并异唑-3-乙酸 在 4-二甲氨基吡啶 、 1-(3-二甲基氨基丙基)-3-乙基碳二亚胺 作用下， 以 二氯甲烷 为溶剂， 反应 0.17h， 以76%的产率得到N-(2-benzo[d]isoxazol-3-yl-acetyl)-methanesulfonamide
  参考文献：
  名称：

  WO2008/142134

  摘要：

  公开号：

文献信息

• BENZISOXAZOLE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS FOR THE TREATMENT OF E.G. RESPIRATORY DISEASES, EPILEPSY AND CONVULSIONS
  申请人：Nardi Antonio

  公开号：US20100168192A1

  公开（公告）日：2010-07-01

  This invention relates to novel benzisoxazole derivatives that are found to be potent modulators of potassium channels and, as such, are valuable candidates for the treatment of diseases or disorders as diverse as those which are responsive to the modulation of potassium channels e.g. a respiratory disease, epilepsy or convulsions. X represents a substituent selected from the group consisting of CO—NR′R″, CO—O—R′, CO—NH—S, CO—NH—SO 2 R″′, CO—NH—C═N, SO 2 —NR′R″, 2,3-dihydro-1-H-tetrazol-5-yl and [1,2,4]oxadiazolidin-5-one; wherein R′ and R″, independently of each other, represent hydrogen or alkyl or phenyl; and R″′ represents alkyl, cycloalkyl, haloalkyl or phenyl, which phenyl may optionally be substituted one or more times with substituents selected from halo, trifluoromethyl, trifluoromethoxy, cyano and nitro.

  本发明涉及新型苯并异噁唑衍生物，这些衍生物被发现是钾通道的有效调节剂，因此是治疗对钾通道调节敏感的疾病或疾病的有价值的候选药物，例如呼吸系统疾病、癫痫或惊厥等。其中，X代表从以下群组中选择的取代基：CO—NR′R″、CO—O—R′、CO—NH—S、CO—NH—SO2R″′、CO—NH—C═N、SO2—NR′R″、2,3-二氢-1H-四唑-5-基和[1,2,4]噁二唑烷-5-酮；其中，R′和R″分别独立地表示氢或烷基或苯基；R″′表示烷基、环烷基、卤代烷基或苯基，其中苯基可以选择性地被一个或多个取代基所取代，所述取代基是从卤、三氟甲基、三氟甲氧基、氰和硝基中选择的。
• [EN] BENZISOXAZOLE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS FOR THE TREATMENT OF E.G. RESPIRATORY DISEASES, EPILEPSY AND CONVULSIONS<br/>[FR] NOUVEAUX DÉRIVÉS DE BENZISOXAZOLE UTILES COMME MODULATEURS DES CANAUX POTASSIQUES
  申请人：NEUROSEARCH AS

  公开号：WO2008142134A1

  公开（公告）日：2008-11-27

  [EN] This invention relates to novel benzisoxazole derivatives that are found to be potent modulators of potassium channels and, as such, are valuable candidates for the treatment of diseases or disorders as diverse as those which are responsive to the modulation of potassium channels e.g. a respiratory disease, epilepsy or convulsions. X represents a subsituent selected from the group consisting of CO-NR'R'', CO-O-R', CO-NH-S, CO-NH-SO₂R''', CO-NH-C=N, SO₂-NR'R'', 2,3-dihydro-1-H-tetrazol-5-yl and [1, 2, 4]oxadiazolidin-5-one; wherein R' and R'', independently of each other, represent hydrogen or alkyl or phenyl; and R''' represents alkyl, cycloalkyl, haloalkyl or phenyl, which phenyl may optionally be substituted one or more times with substituents selected from halo, trifluoromethyl, trifluoromethoxy, cyano and nitro.
  [FR] Cette invention porte sur de nouveaux dérivés de benzisoxazole qui sont trouvés être de puissants modulateurs des canaux potassiques et, en tant que tels, sont des candidats précieux pour le traitement de maladies ou de troubles aussi divers que ceux qui sont sensibles à la modulation des canaux potassiques.
• WO2008/142134
  申请人：——

  公开号：——

  公开（公告）日：——